Happy Friday, all! This is Meghana of Team Readout filling in for Ed today. We’ve reached the end of a rather hectic J.P. Morgan week, so kindly take some time during this glorious long weekend to rest, relax, and ready yourself for the forthcoming insanity that the rest of the month is sure to provide. Pharmalittle is on holiday Monday for MLK Day, but Ed will be back Tuesday with the morning menu of headlines.
Merck will use Peter Thiel-backed Palantir Technologies to analyze its extensive pharma, life sciences, and chemical data in hopes to develop and bring products to market more rapidly, Bloomberg writes. This is the first step of a long-term partnership that gives Palantir a stake in Merck’s resulting profits.
About the Author Reprints
